About Vinci Pharmaceuticals
Vinci Pharmaceuticals is a private company based in Avon by the Sea, New Jersey. It has reported $21,218,331 raised in two offerings on Form D since August 2019. Its chief executive is Philip Gioia.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jan 2, 2026 | Jan 26, 2026 | $20,218,331of $25.3M target | 53 | $381K | Equity, Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Aug 2, 2019 | Aug 15, 2019 | $1,000,000of $4.0M target | 1 | $1.0M | Debt, Securities on exerciseRule 506(b) | Form D ↗ |
| Total, two offerings | $21,218,331 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Vinci Pharmaceuticals's Form D filed Jan 26, 2026.
SH
RL
Richard Lindstrom
Director
SK
Sigurd Kirk
Director
NJ
Neil Austrian Jr.
Director
PG
Philip Gioia
Chief Executive Officer and director